Haemonetics CorporationHAENYSE

Revenue (LTM)

$1.4B

+4.0% YoY

Net Income (LTM)

$168M

+42.6% YoY

Free Cash Flow

$142M

Revenue CAGR (5Y)

+11.8%

Marginsimproving

FCF$0.1B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	870	993↑14.1%	1,169↑17.7%	1,309↑12.0%	1,361↑4.0%
Gross Profit	428	531↑23.9%	623↑17.4%	712↑14.3%	779↑9.4%
Operating Income	90	81↓10.0%	156↑93.2%	165↑5.7%	222↑34.5%
Net Income	79	43↓45.4%	115↑166.1%	118↑1.9%	168↑42.6%
EBITDA	184	192↑4.0%	252↑31.4%	295↑17.2%	356↑20.5%
EPS Diluted	1.55	0.84↓45.8%	2.24↑166.7%	2.29↑2.2%	3.31↑44.5%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	192	259↑34.9%	284↑9.6%	179↓37.1%	307↑71.6%
Total Current Assets	694	756↑9.0%	770↑1.8%	769↓0.1%	935↑21.6%
Total Assets	1,820	1,860↑2.2%	1,935↑4.0%	2,196↑13.5%	2,451↑11.6%
Total Current Liabilities	253	442↑74.5%	252↓43.1%	300↑19.3%	578↑92.5%
Total Liabilities	1,088	1,110↑2.0%	1,117↑0.6%	1,236↑10.6%	1,630↑31.9%
Total Equity	732	749↑2.4%	818↑9.2%	960↑17.4%	821↓14.5%
Total Debt	778	781↑0.3%	766↓1.9%	808↑5.5%	1,225↑51.6%
Net Debt	586	521↓11.0%	481↓7.6%	629↑30.7%	918↑46.0%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	109	172↑58.3%	273↑58.5%	182↓33.4%	182↓0.0%
Capital Expenditure	-37	-97↓160.6%	-110↓14.2%	-66↑39.8%	-39↑40.8%
Free Cash Flow	72	76↑5.6%	163↑115.0%	115↓29.1%	142↑23.4%
Stock-Based Comp	26	24↓4.5%	26↑5.0%	28↑10.7%	30↑4.6%
Net Change in Cash	55	67↑22.2%	25↓62.8%	-106↓523.2%	128↑221.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance